Correlation Between Embrace Change and Canopus BioPharma
Can any of the company-specific risk be diversified away by investing in both Embrace Change and Canopus BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Embrace Change and Canopus BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Embrace Change Acquisition and Canopus BioPharma Incorporated, you can compare the effects of market volatilities on Embrace Change and Canopus BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Embrace Change with a short position of Canopus BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Embrace Change and Canopus BioPharma.
Diversification Opportunities for Embrace Change and Canopus BioPharma
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Embrace and Canopus is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Embrace Change Acquisition and Canopus BioPharma Incorporated in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canopus BioPharma and Embrace Change is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Embrace Change Acquisition are associated (or correlated) with Canopus BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canopus BioPharma has no effect on the direction of Embrace Change i.e., Embrace Change and Canopus BioPharma go up and down completely randomly.
Pair Corralation between Embrace Change and Canopus BioPharma
Given the investment horizon of 90 days Embrace Change is expected to generate 72.5 times less return on investment than Canopus BioPharma. But when comparing it to its historical volatility, Embrace Change Acquisition is 239.22 times less risky than Canopus BioPharma. It trades about 0.22 of its potential returns per unit of risk. Canopus BioPharma Incorporated is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 0.02 in Canopus BioPharma Incorporated on October 17, 2024 and sell it today you would lose (0.01) from holding Canopus BioPharma Incorporated or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Embrace Change Acquisition vs. Canopus BioPharma Incorporated
Performance |
| Timeline |
| Embrace Change Acqui |
| Canopus BioPharma |
Embrace Change and Canopus BioPharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Embrace Change and Canopus BioPharma
The main advantage of trading using opposite Embrace Change and Canopus BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Embrace Change position performs unexpectedly, Canopus BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canopus BioPharma will offset losses from the drop in Canopus BioPharma's long position.| Embrace Change vs. China Health Management | Embrace Change vs. Absolute Health and | Embrace Change vs. Supurva Healthcare Group | Embrace Change vs. TransAKT |
| Canopus BioPharma vs. WK Kellogg Co | Canopus BioPharma vs. Hooker Furniture | Canopus BioPharma vs. John B Sanfilippo | Canopus BioPharma vs. Sysco |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |